Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research ...

Scientists reveal what vaccines are really capable of As new COVID-19 variants continue to emerge, widespread concerns have ...

As an unplanned overall survival (OS) analysis of ivonescimab’s Keytruda head-to-head trial rocked the PD- (L)1xVEGF world, ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

Pfizer PFE reported first-quarter 2025 adjusted earnings per share of 92 cents, which comprehensively beat the Zacks ...

When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday. March 10, 2025 BioNTech guides for worse-than ...

BioNTech to present clinical & pre-clinical data from mRNA and next-generation immuno-oncology priority programmes at AACR 2025: Mainz, Germany Saturday, April 26, 2025, 14:00 Hrs ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...